ScholarIQanswers from OpenAlex & ORCID
Bassel F. El‐Rayes
ResearcherPublications, citations & collaboration network
Bassel F. El‐Rayes is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bassel F. El‐Rayes have?
ScholarIQindexed works
Bassel F. El‐Rayes has 674 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bassel F. El‐Rayes have?
ScholarIQcitation count
Bassel F. El‐Rayes has 16,366 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bassel F. El‐Rayes?
ScholarIQh-index
Bassel F. El‐Rayes has an h-index of 64 in OpenAlex.
What is the i10-index of Bassel F. El‐Rayes?
ScholarIQi10-index
Bassel F. El‐Rayes has an i10-index of 230 in OpenAlex.
What is the ORCID of Bassel F. El‐Rayes?
ScholarIQorcid
The ORCID for Bassel F. El‐Rayes is on the source record.
What is the OpenAlex record for Bassel F. El‐Rayes?
ScholarIQopenalex
The OpenAlex for Bassel F. El‐Rayes is on the source record.
What are the most-cited papers on Bassel F. El‐Rayes?
ScholarIQmost cited works
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker, Berend R. Beumer, Eran Sadot, Lysiane Marthey, Jason E. Faris, Eric A. Mellon, Bassel F. El‐Rayes, Andrea Wang‐Gillam, Jill Lacy, Peter J. Hosein, Sing Yu Moorcraft, Thierry Conroy, Florian Hohla, Peter J. Allen, Julien Taı̈eb, Theodore S. Hong, Ravi Shridhar, Ian Chau, Casper H.J. van Eijck, Bas Groot Koerkamp
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
İbrahim Halil Şahin, Mehmet Akce, Olatunji B. Alese, Walid L. Shaib, Gregory B. Lesinski, Bassel F. El‐Rayes, Christina Wu
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen, Stefan Buettner, Mustafa Suker, Berend R. Beumer, Pietro Addeo, Philippe Bachellier, Nathan Bahary, Tanios Bekaii‐Saab, Maria Antonietta Bali, Marc G. Besselink, Brian A. Boone, Ian Chau, Stephen Clarke, Mary Dillhoff, Bassel F. El‐Rayes, Jessica M. Frakes, Derek Grose, Peter J. Hosein, Nigel B. Jamieson, Ammar A. Javed, Khurum Khan, Kyu-pyo Kim, Song Cheol Kim, Sunhee S. Kim, Andrew H. Ko, Jill Lacy, Georgios Antonios Margonis, Martin D. McCarter, Colin J. McKay, Eric A. Mellon, Sing Yu Moorcraft, Ken‐ichi Okada, Alessandro Paniccia, Parag J. Parikh, Niek A. Peters, Hans Rabl, Jaswinder S. Samra, Christoph Tinchon, Geertjan van Tienhoven, Eran van Veldhuisen, Andrea Wang‐Gillam, Matthew J. Weiss, Johanna W. Wilmink, Hiroki Yamaue, Marjolein Y.V. Homs, Casper H.J. van Eijck, Matthew H. G. Katz, Bas Groot Koerkamp
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Anne M. Noonan, Matthew R. Farren, Susan Geyer, Ying Huang, Sanaa Tahiri, Daniel H. Ahn, Sameh Mikhail, Kristen K. Ciombor, Shubham Pant, Santiago Aparo, Jennifer Sexton, John L. Marshall, Thomas A. Mace, Christina Wu, Bassel F. El‐Rayes, Cynthia Timmers, James A. Zwiebel, Gregory B. Lesinski, Miguel A. Villalona‐Calero, Tanios Bekaii‐Saab
The Potential of CAR T Cell Therapy in Pancreatic Cancer
Mehmet Akce, Mohammad Y. Zaidi, Edmund K. Waller, Bassel F. El‐Rayes, Gregory B. Lesinski